Poseida Therapeutics, Inc. Deferred Revenue (Non-Current)
Poseida Therapeutics, Inc. had Deferred Revenue (Non-Current) of $48.40 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2024-11-07
- 2024-09-30: Deferred Revenue, Noncurrent $48.40M.
- 2024-06-30: Deferred Revenue, Noncurrent $54.92M.
- 2024-03-31: Deferred Revenue, Noncurrent $11.90M.
- 2023-12-31: Deferred Revenue, Noncurrent $16.78M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2024-09-30 | $48.40M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $54.92M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $11.90M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $16.78M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $18.79M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $8.46M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $19.06M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $21.33M 10-K · filed 2024-03-07 |
| 2022-09-30 | $25.29M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $8.81M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $8.97M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $9.27M 10-K · filed 2023-03-09 |